A

Alibaba Health Information Technology Ltd
HKEX:241

Watchlist Manager
Alibaba Health Information Technology Ltd
HKEX:241
Watchlist
Price: 3.61 HKD -4.75% Market Closed
Market Cap: 58B HKD
Have any thoughts about
Alibaba Health Information Technology Ltd?
Write Note

Alibaba Health Information Technology Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alibaba Health Information Technology Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
A
Alibaba Health Information Technology Ltd
HKEX:241
Cash from Financing Activities
-ÂĄ2B
CAGR 3-Years
-229%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
China Ruyi Holdings Ltd
HKEX:136
Cash from Financing Activities
ÂĄ3.6B
CAGR 3-Years
369%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cybernaut International Holdings Co Ltd
HKEX:1020
Cash from Financing Activities
ÂĄ6.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-20%
Y
YesAsia Holdings Ltd
HKEX:2209
Cash from Financing Activities
-$2m
CAGR 3-Years
33%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Hong Kong Technology Venture Co Ltd
HKEX:1137
Cash from Financing Activities
-HK$278.6m
CAGR 3-Years
-48%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Y
Yoho Group Holdings Ltd
HKEX:2347
Cash from Financing Activities
-HK$23.4m
CAGR 3-Years
-1%
CAGR 5-Years
-62%
CAGR 10-Years
N/A
No Stocks Found

Alibaba Health Information Technology Ltd
Glance View

Market Cap
58B HKD
Industry
Retail

Alibaba Health Information Technology Ltd. is a key player in the rapidly evolving landscape of digital healthcare in China, one of the world's largest markets for health services. This innovative subsidiary of Alibaba Group was founded in 2014, aiming to harness the power of advanced technology to enhance healthcare accessibility and efficiency. By leveraging big data, artificial intelligence, and cloud computing, Alibaba Health develops a comprehensive ecosystem that connects patients and healthcare providers seamlessly. Their platforms enable users to book appointments, purchase medications online, and access personalized health information, thereby improving overall health management for millions of individuals across China. As an investor, one cannot overlook Alibaba Health's strategic position in the booming digital healthcare sector fueled by an aging population and rising health awareness among Chinese consumers. The company has established significant partnerships with hospitals, pharmacies, and other healthcare stakeholders, facilitating integration across the health system. With its robust technological infrastructure and the backing of the Alibaba Group, Alibaba Health is well-equipped to capitalize on emerging trends and regulatory shifts in China's healthcare environment. Their ambitious growth strategy and commitment to innovation position them as a potential long-term investment, promising not only strong financial returns but also a meaningful impact on the lives of individuals seeking quality healthcare services.

Intrinsic Value
2.69 HKD
Overvaluation 26%
Intrinsic Value
Price
A

See Also

What is Alibaba Health Information Technology Ltd's Cash from Financing Activities?
Cash from Financing Activities
-2B CNY

Based on the financial report for Sep 30, 2024, Alibaba Health Information Technology Ltd's Cash from Financing Activities amounts to -2B CNY.

What is Alibaba Health Information Technology Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-229%

Over the last year, the Cash from Financing Activities growth was -1 481%. The average annual Cash from Financing Activities growth rates for Alibaba Health Information Technology Ltd have been -229% over the past three years .

Back to Top